Biologics Manufacturing Korea 2020
Since 2012, Biologics Manufacturing Korea has witnessed huge success in bringing over 550 biologics industry pioneers from both Korea and overseas. With the mission to facilitate the development and manufacturing of high-quality biologic drugs and vaccines in Korea for the world market, Biologics Manufacturing Korea is going to continue its legacy.
Changwon Ji Daewoong Pharmaceutical
Eun Young Yang Samsung Biologics
Robert Wonsang Yu Yuyu Pharma
Kyoung E Kim CKD Pharm
Allen Ho JHL Biotech
Shinya Takuma Chugai Pharma
Jin Cai (Jimmy) Lee Wuxi Biologics
Jackal Tsou Mycenax Biotech Inc
Ruediger Mechsner Biotecs
Sushant Sahastrabuddhe International Vaccine Institute
Jina Kim Ministry of Food and Drug Safety
Shuichi Yamamoto Yamaguchi University Biomedical Engineering Center
Takayuki Horiuchi Chitose Laboratory Corp
Hyun Joo An Chungnam National University
Minwoo Kim Hanmi Pharmaceuticals
David Lee Chief Executive Officer, CB Theranostics Inc
Paul Liu WuXi Biologics
Position your products & services in front of senior decision-makers from both the global and Korean biopharmaceutical industry at the Biologics Manufacturing Korea 2020. You get exclusive one-to-one access to key stakeholders to present your expertise through a variety of available thought leadership, branding and exhibitor packages.
Get in touch with us about your needs today!
An update in Korean Biopharmaceutical Facilities
A closer look at Korean & International CMOs
Survey Report of the past event
Songdo, also previously knowns as the Songdo International Business District was built from scratch, on reclaimed land from the Yellow Sea. The 1,500-acre development sits an hour outside of Seoul and is officially part of the city of Incheon, whose proximity to the international airport and the sea makes it both a transportation hub and the gateway to Korea.
It’s the heart of the greater Songdo city, and from its conception in 2001, the IBD was envisioned as a sustainable, low-carbon, and high-tech utopia. For Koreans, the city would have all the perks of Seoul—and more—but without the capital city’s air pollution, crowded sidewalks, and choking automotive traffic. And for foreign corporations looking for access to Asian economies, Songdo would be a glitzy business capital to rival Hong Kong and Shanghai.